Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKTX Akari Therapeutics PLC

Market Closed 05-22 16:00:00 EDT

18.27

+13.13

+255.45%

盘后13.25

-5.02-27.48%

19:59 EDT

High18.99	Low8.58	Vol34.04M
Open9.92	D1 Closing5.14	Amplitude202.51%
Mkt Cap20.91M	Tradable Cap15.77M	Total Shares1.14M
T/O421.73M	T/O Rate3,943.50%	Tradable Shares863.27K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKTX","market":"US","secType":"STK","nameCN":"Akari Therapeutics PLC","latestPrice":18.27,"timestamp":1779480000000,"preClose":5.14,"halted":0,"volume":34043140,"hourTrading":{"tag":"盘后","latestPrice":13.25,"preClose":18.27,"latestTime":"19:59 EDT","volume":2204701,"amount":34532502.4553,"timestamp":1779494399856,"change":-5.02,"changeRate":-0.274767,"amplitude":0.344828},"delay":0,"changeRate":2.554474708171206,"floatShares":863273,"shares":1144533,"eps":-26.914133,"marketStatus":"Market Closed","change":13.13,"latestTime":"05-22 16:00:00 EDT","open":9.92,"high":18.989,"low":8.58,"amount":421727167.26908,"amplitude":2.025097,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-26.914133,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":1,"adrRate":2000,"exchange":"NASDAQ","adjPreClose":5.14,"preHourTrading":{"tag":"盘前","latestPrice":9.92,"preClose":5.14,"latestTime":"09:29 EDT","volume":3246642,"amount":33964755.022926,"timestamp":1779456599069,"change":4.78,"changeRate":0.929961,"amplitude":1.214008},"postHourTrading":{"tag":"盘后","latestPrice":13.25,"preClose":18.27,"latestTime":"19:59 EDT","volume":2204701,"amount":34532502.4553,"timestamp":1779494399856,"change":-5.02,"changeRate":-0.274767,"amplitude":0.344828},"volumeRatio":26.879499372226185},"requestUrl":"/m/hq/s/AKTX","defaultTab":"news","newsList":[{"id":"2637944347","title":"Stocks to Watch: Akari Therapeutics, BlackSky Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2637944347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637944347?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:35","pubTimestamp":1779489300,"startTime":"0","endTime":"0","summary":"Akari Therapeutics said it entered a securities purchase agreement for a private placement. The stock dropped 26% to $13.48 in after-hours trading Friday.BlackSky Technology entered a sales agreement to offer and sell up to $250 million of Class A stock. Shares declined 3% to $46.49 after closing up 7%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKSY","BK4539","LENZ","AKTX","BK4123","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637341929","title":"Akari Therapeutics Stock (AKTX) Explodes 242% on Strong Cancer Drug Data and $5.5M Funding Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2637341929","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637341929?lang=en_us&edition=fundamental","pubTime":"2026-05-23 03:38","pubTimestamp":1779478696,"startTime":"0","endTime":"0","summary":"Akari Therapeutics ($AKTX) jumped over 241.8% on Friday. The upside came after the company released promising new preclinical data for its lead can...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/akari-therapeutics-stock-aktx-explodes-242-on-strong-cancer-drug-data-and-5-5m-funding-boost?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/akari-therapeutics-stock-aktx-explodes-242-on-strong-cancer-drug-data-and-5-5m-funding-boost?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637346080","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:42 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2637346080","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637346080?lang=en_us&edition=fundamental","pubTime":"2026-05-23 01:42","pubTimestamp":1779471740,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:42 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nAQN2M086T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637834611","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637834611","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637834611?lang=en_us&edition=fundamental","pubTime":"2026-05-23 01:18","pubTimestamp":1779470326,"startTime":"0","endTime":"0","summary":"Dell Technologies'  shares soared 16.6% after Wells Fargo raised its price target to $270 from $180.More than 10.6 million shares of the company traded intraday compared with a daily average of about 8 million.CIBC Capital Markets raised its price target on BlackBerry  to $8.50 from $6, with Analyst Todd Coupland maintaining an outperformer rating on the shares.\"...Management signalled better operating visibility and a clearer path to profitable growth across both QNX and Secure Communications,\" Coupland said in a note to clients.Shares of BlackBerry jumped 18% amid a surge in intraday trading volume to over 34.6 million from a daily average of roughly 15.9 million.Akari Therapeutics  reported positive preclinical data highlighting synergistic cytotoxic activity of AKTX-101 in combination with KRAS inhibition in KRAS-mutated pancreatic cancer models.Shares more than doubled as intraday trading volume catapulted to over 17.2 million from a daily average of about 68,000.Price: 294.87, Ch","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065171311.SGD","BK4007","BK4585","LU1267930227.SGD","BK4543","LU2065170008.USD","LU1235294995.USD","LU1823568750.SGD","LU0211326755.USD","BK4139","BB","LU0310800965.SGD","DLLL","BK4588","LU1046421795.USD","BK4547","LU2065169927.USD","BK4097","LU0496365809.HKD","LU0052756011.USD","LU0128525689.USD","LU0976567544.SGD","BK4170","DELL","LU2065171402.SGD","BK4535","BK4515","LU0211326839.USD","AKTX","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637080348","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2637080348","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637080348?lang=en_us&edition=fundamental","pubTime":"2026-05-22 23:06","pubTimestamp":1779462387,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending slightly higher late Friday morning, edging up 0.11% to 1,880.31 on the S&P Europe Select ADR Index, which has surged 3","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","BK4591","E","NTZ","BK4521","IE00BMPRXR70.SGD","BK4515","BK4139","BK4505","MREO","BK4554","GRFS","AUTL","BK4007","IEUR","SLN","BK4020","BK7142","BK4201","SQNS","NOK","TRIB","BK4107","BK4095","BK4207","SAN","PUK","AKTX","IE00BMPRXN33.USD","SAN.AU","AFG","BK4547","ERIC","BK4117","BCYC","LNOK","BBVA","BK4141","BK4082","BDRX","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637631645","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637631645","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637631645?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:18","pubTimestamp":1779448694,"startTime":"0","endTime":"0","summary":"PicoCELA  shares were up 172% in Friday premarket activity, extending Thursday's 60% rally.Leifras  stock was 113% higher after the company agreed to acquire Tokai Sports.Akari Therapeutics  shares were up 64% after the company reported positive preclinical data for its AKTX-101 investigational drug candidate.MetaVia  stock was 40% higher following a muted session.HCW Biologics  shares were up 25% after the company priced a private securities offering.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4148","MTVA","BK4139","BK7093","AKTS","HCWB","PCLA","BK4007","LFS.AU","BK4020","BK4539","AKTX","LFS","BK4204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357360","title":"Akari reports preclinical AKTX-101 synergy with KRAS inhibitor in pancreatic cancer models","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357360?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:06","pubTimestamp":1779397617,"startTime":"0","endTime":"0","summary":"Akari Therapeutics announced new preclinical results for its lead TROP2-targeting antibody-drug conjugate AKTX-101, with findings already presented in an online abstract tied to the ASCO Annual Meeting 2026.Studies in KRAS-mutated pancreatic cancer models showed AKTX-101 boosted the anti-tumor effect of the KRAS inhibitor adagrasib, supporting a potential combination strategy in hard-to-treat KRAS-driven disease.The company highlighted that similar synergy was not seen with competing TROP2 ADCs that use topoisomerase I inhibitor payloads, a positioning point for AKTX-101’s RNA splicing-modulating PH1 payload.The readout also broadened the strategic rationale for AKTX-101 beyond its current Phase 1 plan, with first-in-human trial start targeted for mid-2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL8WQ0PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637771352","title":"Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of Aktx-101 With Kras Inhibition in Kras-Mutated Pancreatic Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2637771352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637771352?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:01","pubTimestamp":1779397260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA1TNC6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357312","title":"Akari Therapeutics Plc - Initiates Ind-Enabling Studies for Aktx-101, Targets Phase 1 Trial by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357312?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:01","pubTimestamp":1779397260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA1TNC6Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637833726","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2637833726","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637833726?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:05","pubTimestamp":1779375935,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking marginally lower late Thursday morning to 1,863.63 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and oil and gas company Eni , which rose 3.7% each. They were followed by medical device maker EDAP TMS  and petroleum reformer Equinor , which were up 1.3% and 0.7% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and pharmaceutical company Novo Nordisk , which decreased 2.6% each. They were followed by software firm SAP  and biopharmaceutical company DBV Technologies , which were down 2.1% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics  and utilities company National Grid , which advanced 5.4% and 1.4% respectively. They were followed by tobacco company British American Tobacco  and biotech company Autolus Therapeutics , which","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4141","AUTL","IE00BMPRXN33.USD","BK4547","LU1093756325.SGD","NVOH","LU0154236417.USD","LU0006061336.USD","BK7104","BK4207","AKTX","BK4023","BK4585","BK4208","EQNR","IE00BZ1G4Q59.USD","VOD","BK4134","BK4007","LU0084288595.USD","LU0648005311.SGD","NVO","IE00BKVL7J92.USD","E","BK4201","BK4532","NVOX","BK4588","SQNS","LU0162691827.USD","LYG","BTI","DAVA","BK4139","LU0072461881.USD","BK4599","BK4082","SAP","BK4132","BK4521","BK4107","BK4117","NGG","BK7062","IE00BMPRXR70.SGD","LU1093756168.USD","NOK","BK4613","LNOK","LU2543165471.USD","DBVT","BK4075","EDAP","BK4528","BK4020","NCNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637336828","title":"Akari Therapeutics prices $5.5 million unregistered private placement at $3.74 ADS","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336828","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637336828?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:35","pubTimestamp":1779366948,"startTime":"0","endTime":"0","summary":"Akari Therapeutics priced a private placement expected to raise about USD 5.5 million in gross proceeds.Deal includes 1,470,588 unregistered ADSs, or prefunded warrants, priced at USD 3.74 per ADS.Investors also agreed to receive unregistered Series H, Series I, Series J warrants, each exercisable for 1,470,588 ADSs at USD 3.74, subject to shareholder approval.Funding is expected in three tranches with closings scheduled between May 27, 2026 and July 15, 2026.Proceeds are earmarked for working capital, general corporate purposes, and advancing lead ADC candidate AKTX-101 toward a first-in-human Phase 1 trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL8NT8jb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357923","title":"Akari Therapeutics Plc - Gross Proceeds to Be Funded in Three Tranches Between May 27 and July 15, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357923?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:30","pubTimestamp":1779366601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA4G2SWX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637335405","title":"Akari Therapeutics Announces $5.5 Million Private Placement Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2637335405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637335405?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:30","pubTimestamp":1779366601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA4G2SWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637804612","title":"Akari Therapeutics Faces Risk of Further IPR&D Write‑Downs on AKTX‑101 and ADC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2637804612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637804612?lang=en_us&edition=fundamental","pubTime":"2026-05-21 14:00","pubTimestamp":1779343235,"startTime":"0","endTime":"0","summary":"Akari Therapeutics PLC (ADR) (AKTX) has disclosed a new risk, in the Accounting & Financial Operations category. The analyst notes that Akari Thera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-faces-risk-of-further-iprd-write‑downs-on-aktx‑101-and-adc-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-faces-risk-of-further-iprd-write‑downs-on-aktx‑101-and-adc-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKTX","BK4139","BK4007","ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636985076","title":"European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985076","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636985076?lang=en_us&edition=fundamental","pubTime":"2026-05-19 23:27","pubTimestamp":1779204425,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&P Europe Select ADR Index.From continental Europe, the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7507","SAP","CRTO","BHP.AU","SQNS","LU2324357040.USD","SNN","BK4107","BK4588","BK4505","EQNR","IE00BFMHRM44.USD","BK4007","BK4168","EPV","ARGX","IE0034235188.USD","BK7095","BK4528","BK4117","LU0300736492.USD","IE0002141913.USD","AUTL","BHP","BK4139","LU0889565916.HKD","NOK","AFG","BK7511","LU0109394709.USD","BK4547","IE00BJJMRZ35.SGD","IEUR","LU1983260115.SGD","EDAP","IE00BFTCPJ56.SGD","SLN","LNOK","BK4201","BK4009","BK4020","AKTX","BK4023","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00BMPRXR70.SGD","CLLS","IE0009355771.USD","NCNA","BDRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636001145","title":"Akari Therapeutics delays quarterly report filing for March 31, 2026 quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2636001145","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636001145?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:15","pubTimestamp":1779138956,"startTime":"0","endTime":"0","summary":"Akari Therapeutics filed a late notice for its Form 10-Q for the quarter ended March 31, 2026, citing work tied to a previously announced public offering and related disclosures.The filing is expected within the SEC’s five-calendar-day extension period under Rule 12b-25.The quarterly results are expected to show a significant change from the prior-year period due to a material non-cash impairment charge triggered by a sustained decline in market price and market capitalization versus net asset carrying value.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL238vTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636107690","title":"Akari Therapeutics CEO joins A.G.P. Annual Healthcare Company Showcase fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2636107690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636107690?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:10","pubTimestamp":1779109801,"startTime":"0","endTime":"0","summary":"Akari Therapeutics will take part in A.G.P.’s Annual Healthcare Company Showcase on May 20, 2026.CEO Abizer Gaslightwala is scheduled for a webcast fireside chat.Discussion will focus on Akari’s antibody-drug conjugate pipeline, including its PH1 RNA-splicing payload platform and lead TROP2 program AKTX-101.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL6b5xzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","AKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635467777","title":"European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2635467777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635467777?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:04","pubTimestamp":1778771099,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.43% to 1,852.92 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and 3D printer company Materialise , which climbed 11.4% and 10.4% respectively. They were followed by lender ING Group  and biopharmaceutical company Cellectis , which increased 2.3% and 2.1% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet browser company Opera , which fell 1.7% and 1.6% respectively. They were followed by oil and gas company Eni  and lender Banco Santander , which were off 1.3% and 0.5% respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Akari Therapeutics , which advanced 9.6% and 3.2% respectively. They were followed by communications company WPP  and lender Barclays , which were up 2.8% and 2.4% respectiv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","AMRN","LU1829250122.USD","BK4107","BK7141","BK4117","LU0154236417.USD","BK4568","LU0889565916.HKD","AKTX","BK4023","BK4009","LU2237443895.HKD","BK7505","LU0300736492.USD","NVO","BK4168","NVOH","SAN","LU0109394709.USD","BK4139","LU2237443465.HKD","AZN","LU2417539215.USD","BK7104","BK4141","BK7511","MTLS","LU2237443978.SGD","NCNA","LU0289739699.SGD","AUTL","BCS","BK7507","ING","BK4521","LU0320765992.SGD","LU2462157665.USD","E","BK4585","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4207","LU2237443549.SGD","BHP","BK4546","BK4599","LU0300736062.USD","LU2456880835.USD","NVOX","LU1093756325.SGD","LU2237443622.USD","LU1093756168.USD","AZNH","BK4588","LU2236285917.USD","BK4532","BK7142","BK4201","SQNS","IE00B3T34201.USD","WPP","LU2237443382.USD","IE00BKVL7J92.USD","CLLS","BK4007","OPRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635733936","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:22 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2635733936","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635733936?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:22","pubTimestamp":1778682134,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:22 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nAQN2LYSNE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AKTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634436482","title":"European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2634436482","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634436482?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:14","pubTimestamp":1778598868,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.From continental Europe, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4141","BK4546","IE00BMPRXN33.USD","LU0006061336.USD","BK4142","BK4207","GSK","AKTX","BK4023","CLLS","BK4585","VOD","IE00BFMHRM44.USD","BK4007","OPRA","IEUR","MREO","BK4532","EPV","BK4588","TRVG","CRTO","SQNS","LU0162691827.USD","LYG","BTI","LU0072461881.USD","BK4139","AFG","BK4132","BK4521","SLN","BK4107","BK4117","GSKH","BK7062","MTLS","GSK.UK","IE00BMPRXR70.SGD","NOK","LU1829250122.USD","CUK","BK4505","LNOK","LU2543165471.USD","DBVT","BK4075","BK4077","BK4020","BTI.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akaritx.com","stockEarnings":[{"period":"1week","weight":4.235},{"period":"1month","weight":2.1554},{"period":"3month","weight":0.9305},{"period":"6month","weight":0.015},{"period":"1year","weight":-0.636},{"period":"ytd","weight":0.5804}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.007289},{"month":2,"riseRate":0.25,"avgChangeRate":-0.164819},{"month":3,"riseRate":0.384615,"avgChangeRate":0.051328},{"month":4,"riseRate":0.461538,"avgChangeRate":0.052868},{"month":5,"riseRate":0.230769,"avgChangeRate":0.040693},{"month":6,"riseRate":0.5,"avgChangeRate":0.049768},{"month":7,"riseRate":0.333333,"avgChangeRate":0.024132},{"month":8,"riseRate":0.5,"avgChangeRate":0.23135},{"month":9,"riseRate":0.5,"avgChangeRate":0.047326},{"month":10,"riseRate":0.25,"avgChangeRate":-0.130903},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.07207},{"month":12,"riseRate":0.25,"avgChangeRate":-0.096768}],"exchange":"NASDAQ","name":"Akari Therapeutics PLC","nameEN":"Akari Therapeutics PLC","securityTypeName":"DR","adrRate":"1:2000"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Akari Therapeutics PLC,AKTX,Akari Therapeutics PLC股票,Akari Therapeutics PLC股票老虎,Akari Therapeutics PLC股票老虎国际,Akari Therapeutics PLC行情,Akari Therapeutics PLC股票行情,Akari Therapeutics PLC股价,Akari Therapeutics PLC股市,Akari Therapeutics PLC股票价格,Akari Therapeutics PLC股票交易,Akari Therapeutics PLC股票购买,Akari Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akari Therapeutics PLC(AKTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Akari Therapeutics PLC(AKTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction